Actual Medicinal Product (AMP) Lymecycline 408mg capsules (Morningside Healthcare Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

No stability data available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Tetralysal 300mg(408mg) capsules (Galderma (U.K.) Limited and Lymecycline 408mg Capsules (Morningside Healthcare Ltd).

Generic

Lymecycline

Formulation

Lymecycline 408mg capsules

Alternative Suppliers (19)

Tetralysal 300 capsules (Galderma (UK) Ltd)

Tetralysal 300 capsules (DE Pharmaceuticals)

Lymecycline 408mg capsules (Teva UK Ltd)

Lymecycline 408mg capsules (A A H Pharmaceuticals Ltd)

Lymecycline 408mg capsules (Alliance Healthcare (Distribution) Ltd)

Lymecycline 408mg capsules (DE Pharmaceuticals)

Lymecycline 408mg capsules (Sigma Pharmaceuticals Plc)

Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd)

Lymecycline 408mg capsules (Morningside Healthcare Ltd)

Lymecycline 408mg capsules (Somex Pharma)

Lymecycline 408mg capsules (Medihealth (Northern) Ltd)

Lymecycline 408mg capsules (AAH Hillcross)

Tetralysal 300 capsules (Waymade Healthcare Plc)

Lymecycline 408mg capsules (Waymade Healthcare Plc)

Lymecycline 408mg capsules (Kent Pharma (UK) Ltd)

Lymecycline 408mg capsules (Mawdsley-Brooks & Company Ltd)

Lymecycline 408mg capsules (NorthStar Healthcare Unlimited Company)

Tetralysal 300 capsules (Necessity Supplies Ltd)

Lymecycline 408mg capsules (Accord-UK Ltd)

Related Formulations (1)

Lymecycline 408mg capsules